Illumina will offer its DRAGEN analysis software on Nvidia’s accelerated computing platforms through the next-gen sequencing ...

ILMN teams up with NVIDIA to advance technology platforms for the analysis and interpretation of multiomic data.

It operates through the Core Illumina segment, which serves customers in the research, clinical and applied markets fields, and enables the adoption of a variety of genomic solutions. The firm's ...

NVIDIA starts 2025 by announcing a trio of partnerships and a research collaboration to boost healthcare sector presence.

As genomics enables a new era of heath care, Illumina technology is empowering personalized ... comprehensive next-generation sequencing solutions to the research, clinical, and applied markets.

Illumina is an applied genomics technology company that was founded ... We work across 115 countries and continue to strive to make our solutions simple, scalable and accessible to as many life ...

Bank of America Securities analyst Michael Ryskin maintained a Sell rating on Illumina (ILMN – Research Report) today and set a price target of ...

Nvidia said that it has partnered with companies and organizations in the life sciences industry to use generative AI to ...

Illumina, Inc. (NASDAQ: ILMN), a global leader in genomic sequencing and analysis, today announced it is collaborating with NVIDIA to advance technology platforms for the analysis and interpretation ...

Illumina (ILMN) announced a series of updates to its NovaSeq X Series, delivering the NovaSeq X single-flow-cell system alongside a software upgrade and new kits. The single-flow-cell NovaSeq X ...

Illumina & NVIDIA collaborate to decode biology and propel precision health: San Diego Wednesday, January 15, 2025, 16:00 Hrs [IST] Illumina, Inc., a global leader in genomic sequ ...